Carbetocin Versus Oxytocin and Hemodynamic Effects

• Status: Completed
• Trial end date: 2011-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

A randomized double-blind trial of oxytocin 5 u, carbetocin 100 µg and placebo with hemodynamic response as a primary outcome measure.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Oslo University Hospital
• Treatments: Carbetocin; Oxytocin

Criteria

Inclusion Criteria:

• Healthy pregnant women for planned cesarean section

Exclusion Criteria:

• Bleeding disorders

• Placenta disorders